Biodexa Pharmaceuticals PLC (BDRX)
4.00
-0.86
(-17.70%)
USD |
NASDAQ |
Nov 15, 13:45
Biodexa Pharmaceuticals Net Income (TTM): -8.534M for June 30, 2024
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2024 | -8.534M |
| December 31, 2023 | -8.826M |
| June 30, 2023 | -9.869M |
| December 31, 2022 | -9.251M |
| June 30, 2022 | -6.957M |
| December 31, 2021 | -7.517M |
| June 30, 2021 | -10.70M |
| December 31, 2020 | -27.90M |
| June 30, 2020 | -28.90M |
| December 31, 2019 | -12.98M |
| Date | Value |
|---|---|
| June 30, 2019 | -10.33M |
| December 31, 2018 | -20.21M |
| June 30, 2018 | -24.89M |
| December 31, 2017 | -20.88M |
| June 30, 2017 | -26.40M |
| December 31, 2016 | -26.64M |
| June 30, 2016 | -19.68M |
| December 31, 2015 | -15.39M |
| June 30, 2015 | -17.03M |
| December 31, 2014 | -14.24M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-28.90M
Minimum
Jun 2020
-6.957M
Maximum
Jun 2022
-13.14M
Average
-9.560M
Median
Net Income (TTM) Benchmarks
| Adaptimmune Therapeutics PLC | -72.50M |
| Verona Pharma PLC | -153.72M |
| NuCana PLC | -35.48M |
| Autolus Therapeutics PLC | -233.98M |
| TC BioPharm (Holdings) PLC | -- |